Also trades as: MDP.TO (TSX) · $vol 0M
MEDXF OTC
Medexus Pharmaceuticals Inc.
1W: -8.0%
1M: -12.6%
3M: -7.2%
YTD: +49.1%
1Y: +80.5%
3Y: +50.5%
5Y: +38.6%
$3.34
-0.11 (-3.22%)
Weekly Expected Move ±3.8%
$3
$3
$3
$3
$4
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$147M
-14.3% ▼
5Y CAGR: -0.2%
Total Liabilities
$98M
-17.9% ▼
5Y CAGR: -5.5%
Shareholders Equity
$49M
-6.0% ▼
5Y CAGR: +22.1%
Cash & Investments
$7M
-72.8% ▼
5Y CAGR: -19.0%
Total Debt
$22M
-40.1% ▼
5Y CAGR: -13.1%
Net Debt
$16M
+19.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10M | $13M | $5M | $24M | $7M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $10M | $13M | $5M | $24M | $7M |
| Net Receivables | $14M | $22M | $24M | $13M | $15M |
| Inventory | $21M | $23M | $31M | $35M | $33M |
| Other Current Assets | $1M | $2M | $2M | $376K | $447K |
| Total Current Assets | $49M | $73M | $72M | $81M | $64M |
| Property, Plant & Equip. | $1M | $899K | $778K | $689K | $422K |
| Goodwill & Intangibles | $87M | $81M | $74M | $82M | $72M |
| Long-Term Investments | $0 | -$9M | $0 | $0 | $0 |
| Other Non-Current Assets | $2M | $9M | $0 | $0 | $0 |
| Total Non-Current Assets | $90M | $88M | $83M | $91M | $84M |
| Total Assets | $139M | $161M | $156M | $172M | $147M |
| — Liabilities — | |||||
| Accounts Payable | $12M | $10M | $8M | $6M | $8M |
| Short-Term Debt | $15M | $43M | $16M | $37M | $2M |
| Deferred Revenue | $18M | $28M | $0 | $0 | $0 |
| Other Current Liabilities | $3M | $3M | $3M | $125K | $0 |
| Total Current Liabilities | $48M | $83M | $66M | $97M | $54M |
| Long-Term Debt | $40M | $27M | $34M | $198K | $20M |
| Other Non-Current Liab. | $31M | $27M | $25M | $22M | $25M |
| Total Non-Current Liabilities | $73M | $55M | $59M | $22M | $45M |
| Total Liabilities | $121M | $139M | $125M | $120M | $98M |
| — Equity — | |||||
| Common Stock | $69M | $69M | $76M | $96M | $96M |
| Retained Earnings | -$65M | -$64M | -$64M | -$62M | -$64M |
| Accumulated OCI | $4M | $6M | $6M | $6M | $6M |
| Total Stockholders Equity | $18M | $22M | $30M | $52M | $49M |
| Total Liabilities & Equity | $139M | $161M | $156M | $172M | $147M |
| — Key Metrics — | |||||
| Total Debt | $55M | $70M | $50M | $37M | $22M |
| Net Debt | $45M | $57M | $45M | $13M | $16M |
| Total Investments | $0 | -$9M | $0 | $0 | $0 |